TITLE

Comparative In Vitro and In Silico Analyses of Variants in Splicing Regions of BRCA1 and BRCA2 Genes and Characterization of Novel Pathogenic Mutations

AUTHOR(S)
Colombo, Mara; De Vecchi, Giovanna; Caleca, Laura; Foglia, Claudia; Ripamonti, Carla B.; Ficarazzi, Filomena; Barile, Monica; Varesco, Liliana; Peissel, Bernard; Manoukian, Siranoush; Radice, Paolo
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Several unclassified variants (UVs) have been identified in splicing regions of disease-associated genes and their characterization as pathogenic mutations or benign polymorphisms is crucial for the understanding of their role in disease development. In this study, 24 UVs located at BRCA1 and BRCA2 splice sites were characterized by transcripts analysis. These results were used to evaluate the ability of nine bioinformatics programs in predicting genetic variants causing aberrant splicing (spliceogenic variants) and the nature of aberrant transcripts. Eleven variants in BRCA1 and 8 in BRCA2, including 8 not previously characterized at transcript level, were ascertained to affect mRNA splicing. Of these, 16 led to the synthesis of aberrant transcripts containing premature termination codons (PTCs), 2 to the up-regulation of naturally occurring alternative transcripts containing PTCs, and one to an in-frame deletion within the region coding for the DNA binding domain of BRCA2, causing the loss of the ability to bind the partner protein DSS1 and ssDNA. For each computational program, we evaluated the rate of non-informative analyses, i.e. those that did not recognize the natural splice sites in the wild-type sequence, and the rate of false positive predictions, i.e., variants incorrectly classified as spliceogenic, as a measure of their specificity, under conditions setting sensitivity of predictions to 100%. The programs that performed better were Human Splicing Finder and Automated Splice Site Analyses, both exhibiting 100% informativeness and specificity. For 10 mutations the activation of cryptic splice sites was observed, but we were unable to derive simple criteria to select, among the different cryptic sites predicted by the bioinformatics analyses, those actually used. Consistent with previous reports, our study provides evidences that in silico tools can be used for selecting splice site variants for in vitro analyses. However, the latter remain mandatory for the characterization of the nature of aberrant transcripts.
ACCESSION #
87625264

 

Related Articles

  • Splice Site Mutations in the ATP7A Gene. Skjørringe, Tina; Tümer, Zeynep; Møller, Lisbeth Birk // PLoS ONE;2011, Vol. 6 Issue 4, p1 

    Menkes disease (MD) is caused by mutations in the ATP7A gene. We describe 33 novel splice site mutations detected in patients with MD or the milder phenotypic form, Occipital Horn Syndrome. We review these 33 mutations together with 28 previously published splice site mutations. We investigate...

  • Molecular analysis of two uncharacterized sequence variants of the VHL gene. Martella, Maddalena; Salviati, Leonardo; Casarin, Alberto; Trevisson, Eva; Opocher, Giuseppe; Polli, Roberta; Gross, David; Murgia, Alessandra // Journal of Human Genetics;Nov2006, Vol. 51 Issue 11, p964 

    Mutations in the VHL gene cause von Hippel–Lindau disease, a cancer predisposing syndrome characterized by a variety of benign and malignant neoplasms. We report the molecular characterization of two sequence variants of the VHL gene: a synonymous substitution c.462 A>C in exon 2 and a...

  • Co-transcriptional degradation of aberrant pre-mRNA by Xrn2. Davidson, Lee; Kerr, Alastair; West, Steven // EMBO Journal;5/30/2012, Vol. 31 Issue 11, p2566 

    Eukaryotic protein-coding genes are transcribed as pre-mRNAs that are matured by capping, splicing and cleavage and polyadenylation. Although human pre-mRNAs can be long and complex, containing multiple introns and many alternative processing sites, they are usually processed...

  • Small nucleolar RNA-guided post-transcriptional modification of cellular RNAs. Kiss, Tamás // EMBO Journal;7/15/2001, Vol. 20 Issue 14, p3617 

    The discovery of intervening or intronic sequences and the finding that individual nucleotides can be inserted into and deleted from RNA demonstrated that genetic information can be changed at the RNA level. Post-transcriptional modification of individual ribonucleotides, namely deamination of...

  • Extragenic Accumulation of RNA Polymerase II Enhances Transcription by RNA Polymerase III. Listerman, Imke; Bledau, Anita S.; Grishina, Inna; Neugebauer, Karla M. // PLoS Genetics;Nov2007, Vol. 3 Issue 11, pe212 

    Recent genomic data indicate that RNA polymerase II (Pol II) function extends beyond conventional transcription of primarily protein-coding genes. Among the five snRNAs required for pre-mRNA splicing, only the U6 snRNA is synthesized by RNA polymerase III (Pol III). Here we address the question...

  • A first glimpse at the transcriptome of Physarum polycephalum. Glöckner, Gernot; Golderer, Georg; Werner-Felmayer, Gabriele; Meyer, Sonja; Marwan, Wolfgang // BMC Genomics;2008, Vol. 9, Special section p1 

    Background: Physarum polycephalum, an acellular plasmodial species belongs to the amoebozoa, a major branch in eukaryote evolution. Its complex life cycle and rich cell biology is reflected in more than 2500 publications on various aspects of its biochemistry, developmental biology,...

  • Pre-mRNA Secondary Structures Influence Exon Recognition. Hiller, Michael; Zhaiyi Zhang; Backofen, Rolf; Stamm, Stefan // PLoS Genetics;Nov2007, Vol. 3 Issue 11, pe204 

    The secondary structure of a pre-mRNA influences a number of processing steps including alternative splicing. Since most splicing regulatory proteins bind to single-stranded RNA, the sequestration of RNA into double strands could prevent their binding. Here, we analyzed the secondary structure...

  • A missense mutation in the chloride/proton ClC-5 antiporter gene results in increased expression of an alternative mRNA form that lacks exons 10 and 11. Identification of seven new CLCN5 mutations in patients with Dent’s disease. Ramos-Trujillo, Elena; González-Acosta, Hilaria; Flores, Carlos; García-Nieto, Víctor; Guillén, Encarna; Gracia, Salvador; Vicente, Carmen; Espinosa, Laura; Maseda, Maria; Santos, Fernando; Camacho, Juan; Claverie-Martín, Félix // Journal of Human Genetics;Mar2007, Vol. 52 Issue 3, p255 

    Mutations in the voltage-gated chloride/proton antiporter ClC-5 gene, CLCN5, are associated with Dent’s disease, an X-linked renal tubulopathy. Our interest is to identify and characterize disease-causing CLCN5 mutations, especially those that alter the splicing of the pre-mRNA. We...

  • Genetic Analysis Reveals a Role for the C Terminus of the Saccharomyces cerevisiae GTPase Snu114 During Spliceosome Activation. Brenner, Tamara J.; Guthrie, Christine; Stearns, T. // Genetics;Jul2005, Vol. 170 Issue 3, p1063 

    Snu114 is the only GTPase required for mRNA splicing. As a homolog of elongation factor G, it contains three domains (III–V) predicted to undergo a large rearrangement following GTP hydrolysis. To assess the functional importance of the domains of Snu114, we used random mutagenesis to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics